STOCK TITAN

Kineta, Inc. SEC Filings

KA NASDAQ

Welcome to our dedicated page for Kineta SEC filings (Ticker: KA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Reading Kineta’s filings can feel like parsing a clinical protocol. Phase 1 data tables, milestone-based royalty clauses, and frequent at-the-market equity raises hide in hundreds of pages. If you are hunting for a single sentence on cash runway or the latest VISTA trial update, the raw SEC PDF is a maze.

Stock Titan ends that search frustration. Our AI breaks down every document—from a Kineta quarterly earnings report 10-Q filing to the smallest 8-K—into plain-language highlights. Want instant alerts when a director buys shares? The Kineta Form 4 insider transactions real-time feed is ready. Need the risk-factor redlines in the Kineta annual report 10-K simplified? They are one click away. Even complex 14A tables on Kineta proxy statement executive compensation are summarized so you know exactly how milestones affect bonuses.

Here is what you can do:

  • Track Kineta insider trading Form 4 transactions before catalysts hit.
  • Dive into Kineta earnings report filing analysis to watch R&D spend versus cash on hand.
  • See every Kineta 8-K material events explained, including clinical holds or new licensing deals.
  • Use our dashboards for understanding Kineta SEC documents with AI—no biostatistics degree needed.

Because our system refreshes the moment EDGAR posts, you never miss a disclosure. Whether you monitor Kineta executive stock transactions Form 4 or simply need Kineta SEC filings explained simply, the answers arrive faster than the next press release.

Rhea-AI Summary

Armistice Capital, LLC and Steven Boyd report shared beneficial ownership of 1,823,138 shares of Kineta, Inc. common stock. The filing shows the reporting persons have shared voting and dispositive power over 1,823,138 shares and no sole voting or dispositive power. The cover tables list the percentage of the class as 3.64%, while Item 4(b) later reports the percentage as 12.84% and states the percentage is based on 1,823,138 shares outstanding as of March 28, 2025. The statement explains Armistice Capital is the investment manager of Armistice Capital Master Fund Ltd., the direct holder of the shares, and that Steven Boyd is the managing member of Armistice Capital. The Master Fund disclaims beneficial ownership by virtue of its Investment Management Agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Kineta (KA)?

The current stock price of Kineta (KA) is $0.5746 as of September 19, 2024.

What is the market cap of Kineta (KA)?

The market cap of Kineta (KA) is approximately 7.0M.
Kineta, Inc.

NASDAQ:KA

KA Rankings

KA Stock Data

7.05M
12.26M
Pharmaceutical Preparation Manufacturing
Pharmaceutical Preparations
Link
US
MERCER ISLAND